UK markets closed

CK Life Sciences Int'l., (Holdings) Inc. (LSI.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0410+0.0030 (+7.89%)
As of 08:24AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 418.50M
Enterprise value 1.05B
Trailing P/E 176.96
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.58
Price/book (mrq)0.73
Enterprise value/revenue 0.20
Enterprise value/EBITDA 1.67

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3-56.32%
S&P500 52-week change 324.19%
52-week high 30.0895
52-week low 30.0315
50-day moving average 30.0423
200-day moving average 30.0652

Share statistics

Avg vol (3-month) 348
Avg vol (10-day) 3N/A
Shares outstanding 59.61B
Implied shares outstanding 611.01B
Float 82.4B
% held by insiders 174.98%
% held by institutions 11.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 42.51%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.53
Payout ratio 4444.44%
Dividend date 3N/A
Ex-dividend date 423 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in HKD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.32%
Operating margin (ttm)3.64%

Management effectiveness

Return on assets (ttm)1.24%
Return on equity (ttm)0.41%

Income statement

Revenue (ttm)5.32B
Revenue per share (ttm)0.55
Quarterly revenue growth (yoy)0.30%
Gross profit (ttm)N/A
EBITDA 380.71M
Net income avi to common (ttm)17.25M
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)676.16M
Total cash per share (mrq)0.07
Total debt (mrq)5.93B
Total debt/equity (mrq)141.58%
Current ratio (mrq)1.42
Book value per share (mrq)0.44

Cash flow statement

Operating cash flow (ttm)514.18M
Levered free cash flow (ttm)57.61M